Minoru Sakakibara

Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase

Takashi Mano, Rodney W. Stevens, Kazuo Ando et al. · Bioorganic & Medicinal Chemistry · 2003 · 57 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Nucleotide sequence of A cDNA clone for human aldolase: A messenger RNA in the liver

Minoru Sakakibara, Tsunehiro Mukai, Katsuji Hori · Biochemical and Biophysical Research Communications · 1985 · 51 citations

Life Sciences, Biochemistry, Molecular Biology +7

Human aldolase isozyme gene: the structure of multispecies aldolase B mRNAs

Minoru Sakakibara, Tsunehiro Mukai, Hitomi Yatsuki et al. · Nucleic Acids Research · 1985 · 38 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +7

4-[5-Fluoro-3-[4-(2-methyl-1<i>H</i>-imidazol-1-yl)benzyloxy]phenyl]-3,4,5,6- tetrahydro-2<i>H</i>-pyran-4-carboxamide, an Orally Active Inhibitor of 5-Lipoxygenase with Improved Pharmacokinetic and Toxicology Characteristics

Takashi Mano, Yoshiyuki Okumura, Minoru Sakakibara et al. · Journal of Medicinal Chemistry · 2003 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

N-(2-Hydroxyethyl)-N,2-dimethyl-8-{[(4 R)-5-methyl-3,4-dihydro-2 H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a Novel, Potent, and Selective Acid Pump Antagonist for the Treatment of Gastroesophageal Reflux Disease

Hiroki Mori, Hiroko Tonai‐Kachi, Yasuo OCHI et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 22 citations

Medicine, Medicinal Chemistry, Pharmacology +14